TSPT

Transcept Pharmaceuticals, Inc. News Headlines

$1.71
*  
0.03
1.72%
Get TSPT Alerts
*Delayed - data as of Oct. 30, 2014 9:32 ET  -  Find a broker to begin trading TSPT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    TSPT Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Hercules' Solid Q3 Origination Boosts Yearly Growth Target - Analyst Blog
10/2/2014 11:20:00 AM - Zacks.com


Sector Update: Healthcare Stocks Stretching Out Gains Near Finish Line; Transcept Pharma Jumps Over 20% Following $333 Mln Deal with Privately Held Rival
7/1/2014 3:58:14 PM - MT Newswires


Sector Update: Healthcare
7/1/2014 3:55:59 PM - MT Newswires


Transcept Pharmaceuticals, Inc. (TSPT) Ex-Dividend Date Scheduled for June 04, 2014
6/3/2014 9:00:01 AM - NASDAQ.com News


Non-Operating Income Hidden In Operating Earnings
6/18/2013 7:47:00 AM - Seeking Alpha


SmithOnStocks Opines On Stocks: May 19th Edition
5/19/2013 8:32:00 PM - Seeking Alpha


SmithOnStocks Opines On Recent Biotech News
5/13/2013 5:38:00 AM - Seeking Alpha


Transcept: Throwing In The Towel On Intermezzo
5/9/2013 10:46:00 AM - Seeking Alpha


Narrower-than-Expected Loss at Seattle Genetics - Analyst Blog
5/8/2013 10:25:10 AM - Zacks.com


AMAG Narrows Loss; Maintains View - Analyst Blog
4/24/2013 4:09:51 PM - Zacks.com


Merck - BMY in HCV Deal - Analyst Blog
4/23/2013 6:09:40 PM - Zacks.com


Merck In-Licenses from Xenon - Analyst Blog
4/22/2013 6:11:06 PM - Zacks.com


PSTI Plans to Start Phase I Study - Analyst Blog
4/19/2013 4:11:14 PM - Zacks.com


Achillion's HCV Candidates Progress - Analyst Blog
4/17/2013 5:12:52 PM - Zacks.com


Actelion Beats Earnings, Sales Rise - Analyst Blog
4/16/2013 7:08:40 PM - Zacks.com


Repros Gets Additional Patents - Analyst Blog
4/12/2013 5:09:02 PM - Zacks.com


Sanofi Unveils Bond Issue Pricing - Analyst Blog
4/9/2013 4:08:12 PM - Zacks.com


Positive Data on Repros' Androxal - Analyst Blog
4/4/2013 5:09:21 PM - Zacks.com


Positive Results on AMAG's Feraheme - Analyst Blog
3/18/2013 6:47:01 PM - Zacks.com


Alexion Pharma Upgraded to Outperform - Analyst Blog
3/15/2013 2:48:02 PM - Zacks.com


Tonix Readies For Pivotal Fibromyalgia Program
3/13/2013 5:35:09 AM - SeekingAlpha


Transcept: The Prescription Trend Watch For Intermezzo Is On
2/14/2013 6:29:00 PM - Seeking Alpha


Transcept: Purdue Fires Big Marketing Guns And FDA Issues Insomnia Drug Guidelines That Help Intermezzo
1/23/2013 5:35:00 AM - Seeking Alpha


Transcept: Direct To Consumer Advertising Campaign Could Be Tipping Point For Intermezzo
12/7/2012 3:16:00 PM - Seeking Alpha


What Is Next For Transcept Pharmaceuticals After Disappointing Intermezzo Launch?
12/6/2012 1:20:00 PM - Seeking Alpha